Status:
COMPLETED
Gut Microbiota in Intestinal Barrier Damage in Acute Leukemia Patients Undergoing Inpatient Induction
Lead Sponsor:
Masonic Cancer Center, University of Minnesota
Conditions:
Chemotherapy-Induced Gut Barrier Damage
Acute Leukemia
Eligibility:
All Genders
18-99 years
Brief Summary
This is an observational study to collect stool, blood, and urine from acute leukemia patients undergoing induction chemotherapy in order to generate preliminary data regarding the association between...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Adults (ages 18 - 99 years) undergoing inpatient induction chemotherapy for newly diagnosed or relapsed acute leukemia (myeloid or lymphoblastic).
- Any induction regimen (standard or experimental) with planned \~4 weeks of inpatient stay
- Able to provide written voluntary consent before performance of any study related procedure.
Exclusion
Key Trial Info
Start Date :
August 22 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2019
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03316456
Start Date
August 22 2017
End Date
April 1 2019
Last Update
May 6 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Masonic Cancer Center at University of Minnesota
Minneapolis, Minnesota, United States, 55455